CIK 0001070494
- Large accelerated filer
ACADIA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ACAD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 061376651
- Phone
- +1 858-558-2871
- Business address
- 12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 2,340,314 shares at an average $14.34 ($33,563,306)
- 4 Open-market buy Director bought 1,993,000 shares at $12.50 ($24,912,500)
- 4 Open-market sale CEO sold 40,000 shares at an average $12.52 ($500,914)
- 4 Open-market sale VP AND GC sold 10,000 shares at $13.15 ($131,493)
- 4 Open-market sale VP AND GC sold 50,000 shares at an average $12.37 ($618,600)
- 4 Open-market sale CEO sold 16,729 shares at $12.32 ($206,048)
- 4 Open-market sale VP AND GC sold 60,000 shares at an average $12.42 ($745,400)
Page 24 of 35 · 686 filings